[go: up one dir, main page]

ZA796148B - Substituted5-(2-imidazolin-2-yl)-aminopyrimidines - Google Patents

Substituted5-(2-imidazolin-2-yl)-aminopyrimidines

Info

Publication number
ZA796148B
ZA796148B ZA00796148A ZA796148A ZA796148B ZA 796148 B ZA796148 B ZA 796148B ZA 00796148 A ZA00796148 A ZA 00796148A ZA 796148 A ZA796148 A ZA 796148A ZA 796148 B ZA796148 B ZA 796148B
Authority
ZA
South Africa
Prior art keywords
aminopyrimidines
imidazolin
Prior art date
Application number
ZA00796148A
Inventor
E Cohnen
W Stenzel
B Armah
W Fleck
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of ZA796148B publication Critical patent/ZA796148B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00796148A 1978-11-15 1979-11-15 Substituted5-(2-imidazolin-2-yl)-aminopyrimidines ZA796148B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (en) 1978-11-15 1978-11-15 Substituted 5- (2-imidazolin-2-yl) aminopyrimidines, processes for their preparation and pharmaceuticals containing them

Publications (1)

Publication Number Publication Date
ZA796148B true ZA796148B (en) 1980-11-26

Family

ID=6054732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00796148A ZA796148B (en) 1978-11-15 1979-11-15 Substituted5-(2-imidazolin-2-yl)-aminopyrimidines

Country Status (4)

Country Link
JP (1) JPS5592383A (en)
BE (1) BE880042A (en)
DE (1) DE2849537C2 (en)
ZA (1) ZA796148B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016767A1 (en) * 1980-04-30 1981-11-05 Beiersdorf Ag, 2000 Hamburg PYRIMIDYLTHIOUROSES, THE MEDICINES CONTAINING THEM AND THEIR USE
DE3423293C2 (en) * 1984-06-23 1995-08-24 Lohmann Therapie Syst Lts Self-adhesive plaster
DE3423328A1 (en) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg SELF-ADHESIVE PLASTER
DE4423177A1 (en) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglycemic drugs
DE19911371A1 (en) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Medicines for the treatment of functional disorders and diseases of the lower intestinal tract, in particular associated abdominal visceral pain
EP1517688A2 (en) 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
BRPI0707308A2 (en) * 2006-01-27 2011-05-03 Hoffmann La Roche use of 2-imidazoles for the treatment of snc disorders
ES2369113T3 (en) * 2006-06-26 2011-11-25 Chemagis Ltd. IMPROVED PROCEDURE TO PRODUCE MOXONIDINE.
RU2473545C2 (en) 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг New 2-aminooxazolines as taar1 ligands for cns diseases
KR101222412B1 (en) 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 2-aminooxazolines as taar1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
DE102012215896A1 (en) 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidine synthesis using organic bases
EP2738165B1 (en) 2012-12-03 2016-10-12 WÖRWAG PHARMA GmbH & Co. KG Method by means of phase transfer catalysis
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
SG11201807516UA (en) 2016-03-17 2018-09-27 Hoffmann La Roche 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (en) * 1969-08-14 1971-02-15 Beecham Group Ltd IMINAZOLINES
BE503170A (en) * 1975-09-02

Also Published As

Publication number Publication date
BE880042A (en) 1980-05-14
JPS6354714B2 (en) 1988-10-28
DE2849537C2 (en) 1983-03-17
JPS5592383A (en) 1980-07-12
DE2849537A1 (en) 1980-05-22

Similar Documents

Publication Publication Date Title
ZA79726B (en) 9-amino-dibenzopyrans
BG27580A1 (en) Two- poled pelvis- thight articulation- set
GB2027917B (en) Shutter-diaphragm
ZA801608B (en) Cylinder-de-activator-system
ZA796148B (en) Substituted5-(2-imidazolin-2-yl)-aminopyrimidines
JPS554499A (en) Extension
IL57137A0 (en) Iniciator
PH14802A (en) 4-amino-2-piperidino-quinazolines
GB2021402A (en) Clotheshanger
GB2033941B (en) Scooper-excavator
YU241679A (en) Episcope
JPS54108154A (en) Vvbelt
ZA795717B (en) M-anilide-urethanes
JPS54150667A (en) Ptccresistor
GB2025291B (en) Torquewrenches
GB2024891B (en) Tunnellingshield
GB2024987B (en) Oil-cooledpiston
GB2052476B (en) Quaternized-polyamines
GB2020459A (en) Sheetcounter
GB1558045A (en) Drumtensioning
ZA794865B (en) Decollators
GB2022469B (en) Fibre-feeder
CS686179A2 (en) Zpusob vyroby fenylchinolizidinu
JPS5515850A (en) Carddholder
GB2028316B (en) Thiopyranobenzopyrans